InvestorsHub Logo
Followers 17
Posts 10861
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Wednesday, 09/13/2023 9:18:53 AM

Wednesday, September 13, 2023 9:18:53 AM

Post# of 44784
Since PLX-R18 cannot be studied using human subjects for ethical reasons, it is being considered for approval through what is called the FDA’s Animal Rule and the European Medicines Agency’s Exceptional Circumstances Pathway. For this reason, the authorities are asking Pluri and its research partners for more refinement.

https://www.timesofisrael.com/israels-pluri-wins-nih-contract-for-drug-that-could-save-lives-in-nuclear-event/
Bullish
Bullish